Balyasny Asset Management L.P. Decreases Stock Position in Huron Consulting Group Inc. (NASDAQ:HURN)

Balyasny Asset Management L.P. cut its position in Huron Consulting Group Inc. (NASDAQ:HURN - Free Report) by 81.1% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 3,020 shares of the business services provider's stock after selling 12,940 shares during the period. Balyasny Asset Management L.P.'s holdings in Huron Consulting Group were worth $375,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds have also recently modified their holdings of HURN. Allspring Global Investments Holdings LLC increased its holdings in Huron Consulting Group by 61.3% in the 4th quarter. Allspring Global Investments Holdings LLC now owns 11,972 shares of the business services provider's stock valued at $1,488,000 after acquiring an additional 4,550 shares during the last quarter. Aigen Investment Management LP bought a new stake in shares of Huron Consulting Group in the 4th quarter valued at approximately $211,000. Congress Asset Management Co. boosted its stake in Huron Consulting Group by 9.0% during the fourth quarter. Congress Asset Management Co. now owns 79,095 shares of the business services provider's stock worth $9,828,000 after buying an additional 6,521 shares during the period. JPMorgan Chase & Co. grew its holdings in Huron Consulting Group by 29.6% during the 4th quarter. JPMorgan Chase & Co. now owns 101,041 shares of the business services provider's stock valued at $12,555,000 after purchasing an additional 23,059 shares during the last quarter. Finally, PEAK6 LLC bought a new position in shares of Huron Consulting Group during the fourth quarter valued at approximately $230,000. 93.90% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In other Huron Consulting Group news, Director H Eugene Lockhart sold 12,500 shares of the company's stock in a transaction dated Wednesday, February 26th. The shares were sold at an average price of $150.00, for a total value of $1,875,000.00. Following the completion of the transaction, the director now owns 12,172 shares in the company, valued at approximately $1,825,800. This represents a 50.66% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO C. Mark Hussey sold 27,672 shares of Huron Consulting Group stock in a transaction that occurred on Tuesday, March 4th. The stock was sold at an average price of $145.91, for a total value of $4,037,621.52. Following the completion of the sale, the chief executive officer now directly owns 81,118 shares in the company, valued at $11,835,927.38. This represents a 25.44% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders have sold 76,239 shares of company stock worth $11,168,801. 2.15% of the stock is owned by company insiders.

Analysts Set New Price Targets

A number of equities research analysts recently issued reports on HURN shares. Truist Financial raised their price target on Huron Consulting Group from $165.00 to $180.00 and gave the stock a "buy" rating in a research note on Tuesday, March 4th. StockNews.com lowered shares of Huron Consulting Group from a "buy" rating to a "hold" rating in a research note on Friday, May 2nd. William Blair restated an "outperform" rating on shares of Huron Consulting Group in a report on Wednesday, March 26th. Benchmark reiterated a "buy" rating and set a $165.00 price objective on shares of Huron Consulting Group in a report on Wednesday, March 26th. Finally, Wedbush boosted their price objective on shares of Huron Consulting Group from $150.00 to $165.00 and gave the company an "outperform" rating in a research report on Wednesday, March 26th. One research analyst has rated the stock with a hold rating and five have given a buy rating to the company's stock. According to data from MarketBeat.com, Huron Consulting Group currently has a consensus rating of "Moderate Buy" and an average price target of $170.75.

Huron Consulting Group Stock Down 0.6%

Shares of Huron Consulting Group stock traded down $0.91 during trading on Tuesday, hitting $152.04. 114,691 shares of the stock traded hands, compared to its average volume of 149,365. The company has a current ratio of 1.61, a quick ratio of 1.61 and a debt-to-equity ratio of 0.82. The stock's fifty day simple moving average is $143.74 and its 200 day simple moving average is $133.17. The firm has a market cap of $2.62 billion, a P/E ratio of 33.05 and a beta of 0.23. Huron Consulting Group Inc. has a 52-week low of $84.87 and a 52-week high of $155.00.

Huron Consulting Group (NASDAQ:HURN - Get Free Report) last issued its quarterly earnings data on Tuesday, April 29th. The business services provider reported $1.68 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.16 by $0.52. Huron Consulting Group had a net margin of 5.80% and a return on equity of 21.51%. The firm had revenue of $404.14 million for the quarter, compared to the consensus estimate of $389.27 million. During the same quarter in the previous year, the firm earned $1.23 EPS. The company's quarterly revenue was up 11.2% compared to the same quarter last year. On average, equities analysts predict that Huron Consulting Group Inc. will post 6.1 earnings per share for the current fiscal year.

Huron Consulting Group Company Profile

Huron Consulting Group Inc, a professional services firm, provides consultancy services in the United States and internationally. It operates through three segments: Healthcare, Education, and Commercial. The Healthcare segment provides financial and operational performance improvement consulting services; digital offerings, spanning technology and analytic-related services; software products; organizational transformation services; revenue cycle managed and outsourcing services; financial and capital advisory consulting services; and strategy and innovation consulting services to national and regional health systems, academic and community health systems, federal health system, public, children's and critical access hospitals, physician practices and medical groups, payors, and long-term care or post-acute providers.